- Orphan Drugs for Rare Diseases: Grounds for Special Status
[作者:Picavet, E; Dooms, M; Cassiman, D; Simoens, S,期刊:Drug Development Research, 页码:115-119 , 文章类型: Article,,卷期:2012年73-3]
- Strategy, Management and Health Policy Enabling Technology, Genomics, Proteomics Preclinical Research Preclinical Development Toxicology, Formulation Drug Delivery, Pharmacokinetics Clinical Development Phases I-III Regu...
- Efficacy of a Poly-L-Glutamic Acid-Gemcitabine Conjugate in Tumor-Bearing Mice
[作者:Kiew, LV; Cheong, SK; Ramli, E; Sidik, K; Lim, TM; Chung, LY,期刊:Drug Development Research, 页码:120-129 , 文章类型: Article,,卷期:2012年73-3]
- Strategy, Management and Health Policy Enabling Technology, Genomics, Proteomics Preclinical Research Preclinical Development Toxicology, Formulation Drug Delivery, Pharmacokinetics Clinical Development Phases I-III Regu...
- Pharmacological and Toxicological Profile of Extract from Heliopsis longipes and Affinin
[作者:Deciga-Campos, M; Arriaga-Alba, M; Ventura-Martinez, R; Aguilar-Guadarrama, B; Rios, MY,期刊:Drug Development Research, 页码:130-137 , 文章类型: Article,,卷期:2012年73-3]
- Strategy, Management and Health Policy Enabling Technology, Genomics, Proteomics Preclinical Research Preclinical Development Toxicology, Formulation Drug Delivery, Pharmacokinetics Clinical Development Phases I-III Regu...
- 3,5-Di-t-Butylcatechol as a Ryanodine Receptor Agonist in Rat Intact Skeletal Muscle Fibers
[作者:Lacava, C; Sgaragli, G; Fusi, F,期刊:Drug Development Research, 页码:138-145 , 文章类型: Article,,卷期:2012年73-3]
- Strategy, Management and Health Policy Enabling Technology, Genomics, Proteomics Preclinical Research Preclinical Development Toxicology, Formulation Drug Delivery, Pharmacokinetics Clinical Development Phases I-III Regu...
- Effects of Silicone-Based Gels Containing Allantoin, Dexpanthenol and Heparin on Hypertrophic Scarring in the Rabbit Ear Model
[作者:Kim, GG; Ku, SK; Lee, DW; Marasini, N; Pradhan, R; Son, MW; Jun, JH; Jang, SW; Jin, SG; Kang, MK; Yong, CS; Choi, HG; Kim, JO,期刊:Drug Development Research, 页码:146-153 , 文章类型: Article,,卷期:2012年73-3]
- Strategy, Management and Health Policy Enabling Technology, Genomics, Proteomics Preclinical Research Preclinical Development Toxicology, Formulation Drug Delivery, Pharmacokinetics Clinical Development Phases I-III Regu...
- In Vivo and In Vitro Studies on the Antioxidant Activity of Aloin Compared to Doxorubicin in Rats
[作者:Esmat, AY; Said, MM; Hamdy, GM; Soliman, AA; Khalil, SA,期刊:Drug Development Research, 页码:154-165 , 文章类型: Article,,卷期:2012年73-3]
- In the present study, the cardiotoxicity of aloin, a naturally occurring anthraquinone glycoside with antiproliferative activitywas compared with doxorubicin, a cardiotoxic anthracyline drug, in rats. The antioxidant and...
|